889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1819320273624629248 |
|---|---|
| author | Patrick Franken Esther Breij Kristel Kemper Rieneke van de Ven Sonja Ganzevles Myrthe Veth Ruud Brakenhoff |
| author_facet | Patrick Franken Esther Breij Kristel Kemper Rieneke van de Ven Sonja Ganzevles Myrthe Veth Ruud Brakenhoff |
| author_sort | Patrick Franken |
| collection | DOAJ |
| first_indexed | 2024-12-24T11:16:58Z |
| format | Article |
| id | doaj.art-bdf003f55a9748d692058832d62544f2 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-24T11:16:58Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-bdf003f55a9748d692058832d62544f22022-12-21T16:58:22ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.889889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivoPatrick Franken0Esther Breij1Kristel Kemper2Rieneke van de Ven3Sonja Ganzevles4Myrthe Veth5Ruud Brakenhoff6Genmab, Princeton, NJ, USA2Genmab A/S, Utrecht, NetherlandsGenmab, Utrecht, Netherlands1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands1Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands |
| spellingShingle | Patrick Franken Esther Breij Kristel Kemper Rieneke van de Ven Sonja Ganzevles Myrthe Veth Ruud Brakenhoff 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo Journal for ImmunoTherapy of Cancer |
| title | 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo |
| title_full | 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo |
| title_fullStr | 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo |
| title_full_unstemmed | 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo |
| title_short | 889 DuoBody®-CD3x5T4 induces efficient T-cell activation and killing of patient-derived head and neck cancer cells in vitro and ex vivo |
| title_sort | 889 duobody r cd3x5t4 induces efficient t cell activation and killing of patient derived head and neck cancer cells in vitro and ex vivo |
| work_keys_str_mv | AT patrickfranken 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT estherbreij 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT kristelkemper 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT rienekevandeven 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT sonjaganzevles 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT myrtheveth 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo AT ruudbrakenhoff 889duobodycd3x5t4inducesefficienttcellactivationandkillingofpatientderivedheadandneckcancercellsinvitroandexvivo |